S2212: Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study

Title
Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
Principal Investigator
Jiang, Bei
Phase
III
Age Group
Adult
Applicable Disease Sites
Breast Cancer
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
United Hospital Center
Contacts
Sabrina Rexroad, RN
Research Nurse
Email:
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Email:
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000
Email:
Kaitlyn Hager
Research Nurse
Email:

View on ClinicalTrials.gov